Redhill Biopharma Ltd Adr (RDHL)

10:18 AM

Taking the lead: Redhill Biopharma Ltd. ADR (RDHL) - Sete News

10:18 AM

10:10 AM

Adversity is less terrifying than hope: Roivant Sciences Ltd (ROIV) - Sete News

10:10 AM

10:08 AM

The time has not yet come to remove your chips from the table: Hertz Global Holdings Inc (HTZ) - Sete News

10:08 AM

10:08 AM

A significant driver of top-line growth: Alexandria Real Estate Equities Inc (ARE) - Sete News

10:08 AM

09:37 AM

Redhill Biopharma Ltd. ADR [RDHL] Insider Activity: An Update for Investors - knoxdaily.com

09:37 AM

Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue - Investing.com

Apr 17, 2025

Apr 17, 2025

RedHill Biopharma faces Nasdaq non-compliance issue By Investing.com - Investing.com India

Apr 17, 2025

Apr 16, 2025

Redhill Biopharma stock hits 52-week low at $1.72 amid market challenges - Investing.com

Apr 16, 2025

Apr 02, 2025

Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com

Apr 02, 2025

Mar 18, 2025

RedHill Biopharma targets UK approval for H. pylori therapy - Investing.com India

Mar 18, 2025

Mar 18, 2025

RedHill Biopharma targets UK approval for H. pylori therapy By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 12, 2025

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results - Placera.se

Mar 12, 2025

Mar 11, 2025

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com

Mar 11, 2025

Feb 25, 2025

What Did We Note About Insider Trading At Redhill Biopharma Ltd. ADR (NASDAQ: RDHL)? - Stocks Register

Feb 25, 2025

Feb 25, 2025

Hyloris secures global rights to RedHill’s RHB-102 - Investing.com India

Feb 25, 2025

Feb 21, 2025

Redhill Biopharma stock hits 52-week low at $4.79 - Investing.com India

Feb 21, 2025

Feb 07, 2025

Earnings call transcript: RedHill Biopharma Q1 2022 sees revenue dip - Investing.com

Feb 07, 2025

Feb 05, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 04, 2025

RedHill tests opaganib with Bayer's drug in prostate cancer study - Investing.com India

Feb 04, 2025

Jan 21, 2025

RedHill stock rises on expanded Medicare coverage - Investing.com

Jan 21, 2025

Jan 21, 2025

RedHill stock rises on expanded Medicare coverage By Investing.com - Investing.com South Africa

Jan 21, 2025

Jan 15, 2025

GAMMA Investing LLC Buys 595 Shares of ArcelorMittal S.A. (NYSE:MT) - Defense World

Jan 15, 2025

Dec 02, 2024

RedHill wins $8 million judgment in New York court - Investing.com India

Dec 02, 2024

Nov 30, 2024

RedHill Biopharma: FDA Accepts TALICIA’s NDA - Investing.com

Nov 30, 2024

Oct 27, 2024

COVID-19 Competitive Landscape 2024 (Updated) - openPR

Oct 27, 2024

Oct 14, 2024

BARDA funds RedHill's opaganib for Ebola treatment - Investing.com

Oct 14, 2024

Oct 01, 2024

Medi-Cal extends Talicia access for 15 million Californians - Investing.com

Oct 01, 2024

Aug 20, 2024

Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com

Aug 20, 2024

Aug 19, 2024

RedHill Biopharma Announces Positive Obesity and Diabetes Results with Opaganib - Investing.com

Aug 19, 2024

Aug 16, 2024

RedHill Biopharma Announces Plan to Implement ADS Ratio Change - PR Newswire

Aug 16, 2024

Mar 01, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 01, 2024

Jan 11, 2024

Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR

Jan 11, 2024

Nov 27, 2023

RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 - PR Newswire

Nov 27, 2023

Apr 19, 2023

Peptic Ulcer Drugs Market Drivers Analysis | CAGR of 3.5% - Market.us

Apr 19, 2023

Apr 17, 2023

Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet - Yahoo Finance

Apr 17, 2023

Feb 24, 2023

Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - markets.businessinsider.com

Feb 24, 2023

Jun 21, 2022

Cathie Wood Predictions 2022 - New Trader U

Jun 21, 2022

Dec 30, 2021

RedHill Biopharma Stock: Looking At An Unexciting Dead-End (NASDAQ:RDHL) - Seeking Alpha

Dec 30, 2021

Jan 11, 2021

RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D - PR Newswire

Jan 11, 2021

Sep 23, 2020

RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib - Yahoo Finance

Sep 23, 2020

Apr 02, 2020

AstraZeneca divestment of Movantik to RedHill Biopharma completed - AstraZeneca

Apr 02, 2020

Jan 21, 2020

RedHill Biopharma to Focus Commercial Efforts on Talicia® - GlobeNewswire

Jan 21, 2020

May 28, 2019

RedHill Biopharma: TALICIA Launch For H. Pylori In Sight - Investing.com

May 28, 2019

Sep 04, 2018

RedHill Biopharma's Drug Pipeline May Merit Substantial Upside, And Potential Catalysts Are On The Horizon - Seeking Alpha

Sep 04, 2018

Jul 15, 2015

RedHill Biopharma files for further Nasdaq offering - גלובס

Jul 15, 2015

Jun 16, 2015

RedHill Biopharma (RDHL) Stock Price, News & Analysis - MarketBeat

Jun 16, 2015